Fundraising is underway for a Nova Scotia girl with a rare genetic condition who has been selected for a clinical trial. The girl, identified as Harper, has a condition that affects her development and quality of life. Her family is now rallying support to cover the costs associated with the trial, which is not covered by public health insurance.
Details of the Clinical Trial
The clinical trial is designed to test a new therapy that could potentially slow or reverse the progression of Harper's condition. According to family representatives, the trial is being conducted at a specialized medical center outside the province, requiring travel and accommodation expenses. The fundraising campaign aims to raise $100,000 to cover these costs and any additional medical needs.
Community Response
The local community has already shown strong support, with several fundraising events planned in the coming weeks. Harper's mother expressed gratitude, saying, 'We are overwhelmed by the outpouring of support. This trial gives us hope we never had before.' The family is also working with a patient advocacy group to raise awareness about the condition and the importance of clinical research.
Impact and Next Steps
If successful, the trial could not only help Harper but also pave the way for treatments for other children with similar genetic disorders. The family is urging people to donate through their official fundraising page and to share Harper's story to increase visibility. The trial is scheduled to begin in August 2026, with results expected within a year.
